Zazove Associates »

Conmed Corp Note 2.250 6/1 shares owned by Zazove Associates

Quarter-by-quarter ownership of Conmed Corp Note 2.250 6/1 shares owned by Zazove Associates from 13F filings

Historical chart of Zazove Associates investment in Conmed Corp Note 2.250 6/1

Tip: Access up to 7 years of quarterly data

All positions including Conmed Corp Note 2.250 6/1 held by Zazove Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conmed Corp Note 2.250 6/1 by Zazove Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 13M 1.00
2023-09-30 $13M 13M 0.95
2023-06-30 $4.8M 4.3M 1.12

More positions owned by Zazove Associates

Ssr Mining In Note 2.500% 4/0 (Principal)
Southwest Airls Note 1.250% 5/0 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)
Nrg Energy DBCV 2.750% 6/0 (Principal)
Ares Capital Corp Note 4.625% 3/0 (Principal)
Middleby Corp Note 1.000% 9/0 (Principal)
Parsons Corp Del Note 0.250% 8/1 (Principal)
John Bean Technologies Corp Note 0.250% 5/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Tyler Tex Indpt Sch Dist Note 0.250% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Braemar Hotels & Resorts Note 4.500% 6/0 (Principal)

View all positions for Zazove Associates

Top funds holding Conmed Corp Note 2.250 6/1

Wolverine Asset Management
Calamos Advisors
MacKay Shields
Millennium Management
Citadel Advisors
Lazard Asset Management
III Capital Management
Wells Fargo & Company
Segantii Capital Management
CSS
Shenkman Capital Management
Zazove Associates
Highbridge Capital Management
Absolute Investment Advisers
Bnp Paribas Arbitrage, Snc

View all funds holding Conmed Corp Note 2.250 6/1